Navigation Links
Anadys Pharmaceuticals to Present at Bio Investor Forum
Date:10/27/2008

uch forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause Anadys' actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. For example, the results of preclinical and early clinical studies may not be predictive of future results, and Anadys cannot provide any assurances that ANA598 and ANA773 will not have unforeseen safety issues, will have favorable results in future clinical trials or will receive regulatory approval. Risk factors that may cause actual results to differ are discussed in Anadys' SEC filings, including Anadys' Form 10-K for the year ended December 31, 2007 and Anadys' Form 10-Q for the quarter ended September 30, 2008. All forward-looking statements are qualified in their entirety by this cautionary statement. Anadys is providing this information as of this date and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.


'/>"/>
SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Anadys Pharmaceuticals to Present at BIO InvestorForum 2007
2. Memory Pharmaceuticals Announces Issuance of Key U.S. Patent for R3487/MEM 3454 and R4996/MEM 63908
3. Access Pharmaceuticals Presents ProLindac(TM) Data at the AACR-NCI-EORTC Symposium 2008
4. Avidas Pharmaceuticals Signs Agreement to Acquire North American Rights to Products That Address Chronic Dermatologic Conditions
5. Genesis Pharmaceuticals Received New Purchase Orders Worth $12 Million
6. ISTA Pharmaceuticals to Present at the Thomas Weisel Partners Healthcare Conference 2008
7. QLT announces agreement to exclusively license the Atrigel(R) Technology to Reckitt Benckiser Pharmaceuticals Inc.
8. Amylin Pharmaceuticals Diabetes Drug Byetta the Focus of California Lawsuit
9. Trubion Pharmaceuticals Announces Appointment of New Chief Medical Officer
10. MiddleBrook Pharmaceuticals Reports Second Quarter 2008 Results
11. Alseres Pharmaceuticals, Inc. Reports Second Quarter 2008 Operational and Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... ... 01, 2015 , ... The 28th annual Charity Horse Show hosted by the ... at 6 p.m. in Pugh Bourne Park, 343 Oakfield Road. The event will again ... an Elvis impersonator, a silent auction and concessions. , Horses and riders from around ...
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... Convoy ... a community celebration in the Twin Cities on Saturday, August 1, at Spring Lake ... Cities community will provide more than $1 million worth of goods and services including ...
(Date:7/1/2015)... ... 01, 2015 , ... RowdMap Inc. is a proud participant ... “Pro-actively Identifying the High-Cost Patient Population: Insights from the Health Care Transformation Task ... http://www.hcttf.org/resouces-tools . , The Healthcare Transformation Task Force is a group of private ...
(Date:7/1/2015)... , ... July 01, 2015 , ... Franklin University, one ... Dr. Leslie King has been named Dean of the College of ... Dr. King will promote and support the vision and mission of Franklin University via ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... summer sale. Customers purchasing two or more Bunion Booties directly from their ... , Bunion Bootie temporarily corrects misaligned toes and its ultra thin properties allow ...
Breaking Medicine News(10 mins):Health News:Convoy of Hope Hosts Community Event in the Twin Cities 2Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 2Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 3Health News:Franklin University Appoints Dean of College of Health & Public Administration 2Health News:Bunion Bootie, the #1 Non-Surgical Treatment for Bunion Pain, Announces Their Big Summer Sale 2
... organs in every brachytherapy procedure should be carefully analyzed ... every patient, according to a new guideline co-authored by ... department of Radiation Oncology at Thomas Jefferson University. ... by the American Association of Physicists in Medicine (AAPM), ...
... behavior, study finds, , MONDAY, Nov. 2 (HealthDay News) ... is linked to aggression in young children. , This ... Archives of Pediatrics & Adolescent Medicine , found that ... indirect viewing in the household were both associated with ...
... ... care legislation pending in Congress, Americans are anxious to see how the ... with reform and advances in medicine on the horizon, nearly 1.5 million ... 50 Million Pound Challenge, which announced this week the loss of its ...
... ... statement on prostate cancer testing, clarifying the Association,s recommendations and support of early detection. ... (Vocus) November ... disparaging prostate cancer testing. We are concerned that these reports are causing significant confusion ...
... 2 IPC The Hospitalist Company, Inc. (Nasdaq: IPCM ... financial results for the third quarter ended September 30, 2009. ... 2008): , Net revenue increased 23% to $77.5 million, ... encounters increased 19% to 823,000 Income from operations rose ...
... Nov. 2 comScore, Inc. (Nasdaq: ... and ImpactRx, a pharmaceutical insights company, today announced the ... only digital measurement solution that connects physicians, online and ... solution is carefully designed to comply with health privacy ...
Cached Medicine News:Health News:Task force develops new radiation guidelines for brachytherapy 2Health News:TV May Increase Aggression in Toddlers 2Health News:TV May Increase Aggression in Toddlers 3Health News:America Battles Obesity, Dropping 5 Million Pounds 2Health News:America Battles Obesity, Dropping 5 Million Pounds 3Health News:AUA Releases Statement Clarifying Prostate Cancer Testing Recommendations 2Health News:AUA Releases Statement Clarifying Prostate Cancer Testing Recommendations 3Health News:IPC The Hospitalist Company Reports Third Quarter 2009 Results 2Health News:IPC The Hospitalist Company Reports Third Quarter 2009 Results 3Health News:IPC The Hospitalist Company Reports Third Quarter 2009 Results 4Health News:IPC The Hospitalist Company Reports Third Quarter 2009 Results 5Health News:IPC The Hospitalist Company Reports Third Quarter 2009 Results 6Health News:IPC The Hospitalist Company Reports Third Quarter 2009 Results 7Health News:IPC The Hospitalist Company Reports Third Quarter 2009 Results 8Health News:IPC The Hospitalist Company Reports Third Quarter 2009 Results 9Health News:IPC The Hospitalist Company Reports Third Quarter 2009 Results 10Health News:IPC The Hospitalist Company Reports Third Quarter 2009 Results 11Health News:IPC The Hospitalist Company Reports Third Quarter 2009 Results 12Health News:IPC The Hospitalist Company Reports Third Quarter 2009 Results 13Health News:comScore Announces Availability of comScore/ImpactRx Physician Behavioral Measurement(TM) Solution 2Health News:comScore Announces Availability of comScore/ImpactRx Physician Behavioral Measurement(TM) Solution 3
(Date:7/1/2015)... Lupin , Strides ... MPP Sub-licensees to Fourteen Companies     ... expansion of its network of generic manufacturers to 14 companies ... antiretrovirals (ARVs). New companies Lupin and Strides Arcolab recently signed ... the MPP licensed from ViiV Healthcare two months after its ...
(Date:7/1/2015)...  AVACEN, Inc. announced today the issue by the US ... technology platform supporting its unique Dry Heat Therapy AVACEN 100 ... - http://photos.prnewswire.com/prnh/20150630/227364LOGO ... - Methods And Apparatus For Therapeutic Application of Thermal Energy ... of use, referred to by the company as the ...
(Date:7/1/2015)... Continental Clinical Solutions (Continental) announced it is expanding its Baltimore -based ... clinical studies and demand for unique patient populations.  ... ... ... "Continental hosts ...
Breaking Medicine Technology:The Medicines Patent Pool Increases its Generic Manufacturing Network to Ramp-Up Production of Low Cost Antiretrovirals (ARVs) 2The Medicines Patent Pool Increases its Generic Manufacturing Network to Ramp-Up Production of Low Cost Antiretrovirals (ARVs) 3AVACEN Medical Patent Issued 2Continental Clinical Solutions CEO Saleh Stevens Eyes Growth 2Continental Clinical Solutions CEO Saleh Stevens Eyes Growth 3Continental Clinical Solutions CEO Saleh Stevens Eyes Growth 4
... Corporation (OTC-PINK: PARS) today announced that it has successfully ... (S-tofisopam) to treat patients with hyperuricemia and gout. This ... Research Unit of Duke University and the principal investigator ... opinion leader in the treatment of gout. The trial ...
... Florida, May 17, 2012 Morgan honored ... , The National Council for Prescription Drug ... 1,500 members throughout the pharmacy services industry, awarded Kay Morgan, ... and Compliance for Elsevier / Gold Standard , with ...
Cached Medicine Technology:Pharmos Corporation Announces Successful Completion Of Proof-of-concept Clinical Trial Of Levotofisopam For The Treatment Of Gout 2Pharmos Corporation Announces Successful Completion Of Proof-of-concept Clinical Trial Of Levotofisopam For The Treatment Of Gout 3Pharmos Corporation Announces Successful Completion Of Proof-of-concept Clinical Trial Of Levotofisopam For The Treatment Of Gout 4Elsevier / Gold Standard's Kay Morgan Awarded NCPCP Highest Honor 2Elsevier / Gold Standard's Kay Morgan Awarded NCPCP Highest Honor 3
Pipetman F is a fixed-volume, air-displacement pipette. Thirteen robust models cover a large volume range from 2 L to 1000 L, with Gilsons legendary accuracy and precision....
... A fixed pipette is ... a single volume. Fixed volume ... and advantages as other Finnpipette ... design, Super blow-out (1-40ul), Soft-touch ...
20L...
20L...
Medicine Products: